The Maharashtra Food and Drug Administration (FDA), on May 5, 2005, decided to ask Johnson and Johnson India (J&J), Wipro and other companies manufacturing baby products to prominently display warnings regarding the side effects of all ingredients contained in the products on their labels. The companies have also been forbidden from making claims about health benefits from their products without the approval of the drug controller general of India, for which they have time till August 1, 2005.
Assistant commissioner FDA, Mumbai, C G Kurunkar says the sale of these products will not be allowed without this approval. "But we have no objection to their sale if the word 'baby' is removed from their names," he adds. FDA has already issued a notice to J&J; notices to other companies are in the pipeline. FDA had earlier given a show cause notice to J&J for "misbranding" its baby products (see Down To Earth, 'Risky care', April 15, 2005). J&J has said it will cooperate fully and comply with the order.
Earlier, on April 20, 2005, Union minister of health and family welfare Anbumani Ramadoss told the Lok Sabha that plans are underway to improve the Drugs and Cosmetics Act, 1940. Suggested changes include removing all unsubstantiated claims from the labels of products and listing all ingredients used in them, even if in negligible quantities.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.